Page last updated: 2024-10-24

celiprolol and Arrhythmias, Cardiac

celiprolol has been researched along with Arrhythmias, Cardiac in 1 studies

Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.

Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.

Research Excerpts

ExcerptRelevanceReference
"In a randomized trial the effect was studied of celiprolol, a cardioselective beta receptor blocker with strong intrinsic activity (ISA) on the incidence of ventricular arrhythmias in patients with acute myocardial infarction (AMI)."5.06[Celiprolol in acute myocardial infarct]. ( Kratzer, H; Kühn, P; Payrhuber, K, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Payrhuber, K1
Kratzer, H1
Kühn, P1

Trials

1 trial available for celiprolol and Arrhythmias, Cardiac

ArticleYear
[Celiprolol in acute myocardial infarct].
    Wiener klinische Wochenschrift, 1986, Mar-21, Volume: 98, Issue:6

    Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Celiprolol; Cr

1986